A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells

Neurological Research

Volumn 31, Issue 5, 2009, Pages 453-462

  Wasita, Brian ^a   Kamitani, Hideki ^a   Kinoshita, Yusuke ^a   Mamun, Mahabub Hasan ^a   Watanabe, Takashi ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Experimental brain tumor; Glioblastoma multiforme; Intracarotid injection; Leptomeningeal gliomatosis; Rat C6 glioma cell

Indexed keywords

GELATINASE A; GELATINASE B; KI 67 ANTIGEN; MATRIX METALLOPROTEINASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN STEM; CACHEXIA; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CAROTID ARTERY; CONTROLLED STUDY; GLIOBLASTOMA; GLIOSIS; HISTOPATHOLOGY; INTRACRANIAL HYPERTENSION; LEPTOMENINX; MALE; NONHUMAN; RAT; SURVIVAL TIME; TUMOR VASCULARIZATION; WEIGHT REDUCTION;

ANIMALS; CACHEXIA; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GLIOBLASTOMA; GLIOMA; IMMUNOHISTOCHEMISTRY; INTRACRANIAL PRESSURE; KI-67 ANTIGEN; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MENINGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RATS; RATS, WISTAR; TUMOR MARKERS, BIOLOGICAL;

EID: 67650128911     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X403904     Document Type: Article

References (34)

1. Watanabe K, Sakamoto M, Somiya M, et al. Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region. Neurol Res 2002; 24: 485-490
2. Sho A, Kondo S, Kamitani H, et al. Establishment of experimental glioma models at the intrinsic brainstem region of the rats. Neurol Res 2007; 29: 36-42
3. Franceschi E, Cavallo G, Scopece L, et al. Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis. J Neurooncol 2005; 73: 261-264
4. Ishige S, Iwadate Y, Ishikura H, et al. Primary diffuse leptomeningeal gliomatosis followed with serial magnetic resonance images. Neuropathology 2007; 27: 290-294
5. Riva M, Bacigaluppi S, Galli C, et al. Primary leptomeningeal gliomatosis: Case report and review of the literature. Neurol Sci 2005; 26: 129-134
6. Yomo S, Tada T, Hirayama S, et al. A case report and review of the literature. J Neurooncol 2007; 81: 209-216
7. Stark AM, Nabavi A, Mehdorn HM, et al. Glioblastoma multiforme - Report of 267 cases treated at a single institution. Surg Neurol 2005; 63 (2): 162-169
8. Kooistra KL, Rodriguez M, Powis G, et al. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res 1986; 46: 317-323
9. Yoshida T, Shimizu K, Ushio Y, et al. Development of experimental meningeal gliomatosis models in rats. J Neurosurg 1986; 65: 503-507
10. Yoshida T, Shimizu K, Ushio Y, et al. [Development of experimental meningeal gliomatosis models using nude mice]. Gan To Kagaku Ryoho 1986; 13: 2745-2750
11. Benda P, Someda K, Messer J, et al. Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture. J Neurosurg 1971; 34: 310-323
12. Fidler IJ, Schackert G, Zhang RD, et al. The biology of melanoma brain metastasis. Cancer Metastasis Rev 1999; 18: 387-400
13. Liu R, Martuza RL, Rabkin SD. Intracarotid delivery of oncolytic HSV vector G47D to metastatatic breast cancer in the brain. Gene Ther 2005; 12: 647-654
14. Mandybur TI. Metastatic brain tumors induced by injection of syngeneic tumor cells into cerebral arterial circulation in rats. Acta Neuropathol (Berl) 1981; 53: 57-63
15. George P, Charles W. The Rat Brain in Stereotaxic Coordinates, 2nd edn, Sydney: Academic Press, 1986
16. Liu L, Rudin M, Kozlova EN. Glial cell proliferation in the spinal cord after dorsal rhizotomy or sciatic nerve transection in the adult rat. Exp Brain Res 2000; 131: 64-73
17. Kim YJ, Romeike BF, Uszkoreit J, et al. Automated nuclear segmentation in the determination of the Ki-67 labeling index in meningiomas. Clin Neuropathol 2006; 25: 67-73
18. Forsyth PA, Wong H, Laing TD, et al. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 1999; 79: 1828-1835
19. Nakagawa T, Kubota T, Kabuto M, et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994; 81: 69-77
20. Smith BK, Conn CA, Kluger MJ. Experimental cachexia: Effect of MCA sarcoma in the Fisher rat. Am J Physiol 1993; 265: 376-384
21. Cooper IS, Kernohan JW. Heterotopic nests in the subarachnoid space; histopathologic characteristics, mode of origin and relation to meningeal gliomas. J Neuropathol Exp Neurol 1951; 10: 16-29
22. Herrlinger U, Buchholz R, Jachimczak P, et al. Intrathecal treatment of C6 glioma leptomeningeal metastasis in Wistar rats with interleukin-2. J Neurooncol 1996; 27: 193-203
23. Deeken JF, Lö scher W. The blood-brain barrier and cancer: Transporters, treatment, and Trojan horses. Clin Cancer Res 2007; 13: 1663-1674
24. Ho KL, Hoschner JA, Wolfe DE. Primary leptomeningeal gliomatosis: Symptoms suggestive of meningitis. Arch Neurol 1981; 38: 662-666
25. Okazaki H, Scheithauer BW. Atlas of Neuropathology, New York: Gower Medical, 1988
26. Johannessen AL, Torp SH. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas. Pathol Oncol Res 2006; 12: 143-147
27. Wakimoto H, Aoyagi M, Nakayama T, et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996; 77: 373-380
28. Apodaca G, Rutka JT, Bouhana K, et al. Expression of metalloproteinase and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res 1990; 50: 2322-2329
29. Nakano A, Tani E, Miyazaki K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 1995; 83: 298-307
30. Yoshida T, Shimizu K, Koulousakis, et al. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model. J Neurosurg 1992; 77: 778-782
31. Yoshida T, Shimizu K, Ushio Y, et al. Treatment of a rat meningeal gliomatosis model with neocarzinostatin. No To Shinkei 1987; 39: 615-619
32. Kramm CM, Rainov NG, Sena-Esteves M, et al. Herpes vectormediated delivery of marker genes to disseminated central nervous system tumors. Hum Gene Ther 1996; 7: 291-300
33. Vincent AJ, Esandi MD, van Someren G, et al. Treatment of leptomeningeal metastases in a rat model using a recombinant adenovirus containing the HSV-tk gene. J Neurosurg 1996; 85: 648-654
34. Myklebust AT, Helseth A, Breistøl K, et al. Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs. J Neurooncol 1994; 21: 215-224